ZBIO Competitors & Alternatives

Compare Zenas BioPharma, Inc. Common Stock with similar stocks in the same industry

Biotechnology

ZBIO

Main Stock
$27.64
-1.32%
Tradestie Score
53
Market Cap
$931.48M
Revenue Growth
-100.0%
Analyst Upside
+73.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: monoclonal antibody engineering, autoimmune immunomodulation
Major Customers 2
clinical trial sites CROs
Critical Suppliers 2
contract manufacturers API suppliers
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
COGT Cogent Biosciences, Inc. Common Stock
$27.64
-3.22%
$1.97B - 39 Compare
OCUL Ocular Therapeutix, Inc.
$5.99
-3.62%
$1.92B - 45 Compare
CELC Celcuity Inc. Common Stock
$61.31
-4.75%
$1.92B - 33 Compare
LQDA Liquidia Corporation Common Stock
$56.82
-1.03%
$1.90B - 30 Compare
VERA Vera Therapeutics, Inc. Class A Common Stock
$27.26
-2.99%
$1.84B - 46 Compare
IMCR Immunocore Holdings plc American Depositary Shares
$29.08
-2.89%
$1.81B - 47 Compare
ABCL AbCellera Biologics Inc. Common Shares
$11.14
-3.08%
$1.78B - 62 Compare
DYN Dyne Therapeutics, Inc. Common Stock
$16.70
-2.71%
$1.78B - 51 Compare
TWST Twist Bioscience Corporation Common Stock
$105.61
-5.37%
$1.77B - 52 Compare
VRDN Viridian Therapeutics, Inc. Common Stock
$30.37
-1.64%
$1.74B - 37 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry